相关实验视频
Updated: Jun 5, 2025

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.2K
实施注射性阿片类药物激动剂治疗的挑战:范围审查
Tanja Schwarz1,2, Deniz Akartuna3, Martin Busch3
1Addiction Competence Centre, Austrian National Public Health Institute (Gesundheit Österreich GmbH, GOEG), Vienna, Austria. tanja.schwarz@goeg.at.
Harm reduction journal
|December 5, 2024
概括
注射性阿片类激素治疗 (iOAT) 面临着诸如公众接受和监管等障碍. 促进者包括政策整合,基于证据的辩论和以患者为中心的护理,以确保成功实施.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生政策 公共卫生政策
- 药理学 药理学是指药理学的学科.
背景情况:
- 注射性阿片类药激剂治疗 (iOAT) 是针对阿片类药物使用障碍的基于证据的干预措施.
- 对于影响iOAT实施和可持续性的因素的理解有限.
- 本研究研究了二甲基摩尔和摩尔IOAT的障碍物和促进因素.
研究的目的:
- 系统地审查和识别用于实施注射性阿片类抗体治疗 (iOAT) 的关键障碍和促进因素.
- 综合有关影响IOAT可行性和可持续性的上下文因素的证据.
- 为成功开发和扩展iOAT计划的战略提供信息.
主要方法:
- 系统地搜索MEDLINE和PsycInfo数据库中的文献,并补充了灰色文献.
- 没有关于出版物类型,年份或地理位置的限制.
- 两名审稿人对有关iOAT可行性,实施或评估的文章进行独立选.
主要成果:
- 障碍包括公众接受问题 (转移,犯罪),法律/道德挑战,负面媒体,高启动成本和严格的法规.
- 促进者包括将IOAT纳入毒品政策,证据传播,伦理委员会监督,公众宣传和成本效益数据.
- 以患者为中心的因素,如灵活的协议,包容性空间和治疗关系,提高了参与度和有效性.
结论:
- 成功实施iOAT需要平衡政治/社会可接受性与科学诚信.
- 战略沟通和公众参与对于克服障碍至关重要.
- 需要进一步的研究,以提高跨不同社会政治背景的可转移性.
更多相关视频
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
223
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
223
Opioid Analgesics: Morphine and Other Natural Cogeners
183
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
183
Analgesia and Pain Management
504
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
504
Drug Delivery: Miscellaneous Routes
320
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
320
Opioid Receptors: Overview
521
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
521
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K

